J Clin Endocrinol Metab 98: 43914399, 2013
consulting fees from Eli Lilly and Company and Boehringer Ingelheim
However, it is essential to note that this study utilised generic liraglutide injections (Nevolat) rather than Mounjaro or its active ingredient, tirzepatide
When appetite is severely suppressed (especially during the early weeks and after dose increases), prioritize protein over all other macronutrients
Semaglutide commonly causes gastrointestinal side effects including nausea, vomiting, and diarrhea, particularly during the initial weeks of treatment or following dose increases
However, there are few study about the effects of liraglutide 1.8 mg for 12 weeks on abdominal fat distribution in Chinese obese population